Longeveron Inc. Reports Q2 2026 Financial Results

What Happened

• Longeveron Inc. announced and furnished a press release on August 12, 2026 reporting its financial and operating results for the three and six months ended June 30, 2026. The release also included certain other business updates and information.
• The press release is attached to the Form 8-K as Exhibit 99.1 and is furnished (not “filed”) under the Exchange Act, per the company’s disclosure.

Key Details

• Press release date: August 12, 2026.
• Reporting periods: three and six months ended June 30, 2026 (Q2 2026 and year-to-date).
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.
• Company disclaimer: the information (including Exhibit 99.1) is furnished and shall not be deemed “filed” under Section 18 of the Exchange Act or incorporated by reference, except as expressly stated.

Why It Matters

• This filing signals Longeveron has released its latest quarterly results and operational updates — important for investors tracking earnings, revenue, cash position, and progress on company initiatives.
• Investors should read the attached press release for the specific financial figures (revenue, profit/loss, cash/runway) and any clinical or business milestones cited, since the Form 8-K itself furnishes the release rather than restating detailed results.